Plumbline Life Sciences, Inc. (XKON:222670)
South Korea · Delayed Price · Currency is KRW
7,740.00
+530.00 (7.35%)
At close: Aug 1, 2025, 3:30 PM KST
Plumbline Life Sciences Balance Sheet
Financials in millions KRW. Fiscal year is January - December.
Millions KRW. Fiscal year is Jan - Dec.
FY 2014 |
---|
Dec '14 Dec 31, 2014 |
---|
| 435.61 |
Cash & Short-Term Investments | 435.61 |
| 53.79 |
| 489.4 |
Property, Plant & Equipment | 2.39 |
| 2,658 |
| 8.69 |
|
| 38.45 |
Current Portion of Long-Term Debt | 1,099 |
Other Current Liabilities | 26.32 |
Total Current Liabilities | 1,164 |
Other Long-Term Liabilities | 987.55 |
|
| 502.15 |
Additional Paid-In Capital | 272.04 |
| -773.99 |
Comprehensive Income & Other | 995.89 |
|
Total Liabilities & Equity | 3,159 |
| 1,099 |
| -663.59 |
| -661.02 |
Filing Date Shares Outstanding | 1 |
Total Common Shares Outstanding | 1 |
| -674.57 |
| 992.23 |
| -1,662 |
Tangible Book Value Per Share | -1655.82 |
Source: S&P Global Market Intelligence. Standard template.
Financial Sources.